Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Topps Tiles appoints former National Express boss as new CEO

(Sharecast News) - Topps Tiles' share price jumped on Thursday after the retailer appointed former National Express boss Alex Jensen as its new chief executive officer and reported a change-up in the chief financial officer role. The tile specialist said that, following current CEO Rob Parker's announced retirement in January, Jensen will join the business in September and work alongside Parker until the end of the year.

Jensen, mostly recently CEO of National Express UK, Ireland and Germany, previously had an extensive career at BP, where she led the transformation of the oil group's retail and B2B fleet services, both as divisional CEO and global chief marketing officer at BP.

"We are delighted to announce the appointment of Alex as the new CEO of the group," said Topps chair Paul Forman.

"Alex brings extensive retail, multi-site and digital experience as well as a proven record of value creation. I am confident that Alex will be instrumental in helping us deliver our goal of Mission 365, creating value for all stakeholders."

Meanwhile, the company also announced that CFO Stephen Hopson is to leave the business for pub chain Marston's, and has appointed Mike Killick as his temporary replacement while the search for a permanent CFO kicks off.

Killick has been CFO across a number of retail, multi-site and public company environments, Topps said, including Pod Point Group, Restore, Peacocks, Thorntons and Jones Bootmaker.

Topps shares were up 5.6% at 37.9p by 0808 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.